On these grounds, BcR IG stereotypy is currently being considered as a means for improved risk stratification of patients with CLL, at least for the best characterized subsets (i.e., subsets #2 and #8) (37). The gene discussed is BCR; the disease is B-cell chronic lymphocytic leukemia.